Navegar por autor "Mesonero, F."

Mostrando ítems 1-10 de 10

A second update on mapping the human genetic architecture of COVID-19

2023- Kanai, M.; Andrews, S.J.; Cordioli, M.; Stevens, C.; Neale, B.M.; [et al.]
Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)

2019- Bastida, G.; Marin-Jimenez, I.; Fores, A.; Garcia-Planella, E.; Arguelles-Arias, F.; [et al.]
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP

2023- Rubín de Célix, C.; Martín-de-Carpi, J.; Pujol-Muncunill, G.; Palomino, L.M.; Velasco Rodríguez-Belvís, M.; [et al.]
Efficacy and safety of tacrolimus in Crohn's disease: a nationwide, multi-centric study from GETECCU

2019- Rodriguez-Lago, I.; Castro-Poceiro, J.; Fernandez-Clotet, A.; Mesonero, F.; Lopez-Sanroman, A.; [et al.]
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity

2022- Guijarro, L.G.; Cano-Martínez, D.; Toledo-Lobo, M.V.; Ruiz-Llorente, L.; Chaparro, M.; [et al.]
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease

2019- Chaparro, M.; Aterido, A.; Guerra, I.; Iborra, M.; Cabriada, J. L.; [et al.]
Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study

2019- Marin-Jimenez, I.; Bastida, G.; Fores, A.; Garcia-Planella, E.; Arguelles-Arias, F.; [et al.]
Impact of comorbidities on anti-TNF alpha response and relapse in patients with inflammatory bowel disease: the VERNE study

2020- Marin-Jimenez, I.; Bastida, G.; Fores, A.; Garcia-Planella, E.; Arguelles-Arias, F.; [et al.]
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

2022- Zabana, Y.; Marín-Jiménez, I.; Rodríguez-Lago, I.; Vera, I.; Martín-Arranz, M.D.; [et al.]
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)

2022- Zabana, Y.; Marín-Jiménez, I.; Rodríguez-Lago, I.; Vera, I.; Martín-Arranz, M.D.; [et al.]